Category: 160377-42-4

On April 20, 2016, Noh, Hyo-Jin; Yoon, Kyung-Jin; Yoon, Dae-Wi; Shin, In-Ae; Kim, Jun-Yun published a patent.Application of 160377-42-4 The title of the patent was Space-through charge transfer compound, and organic light emitting diode and display device using the same. And the patent contained the following:

Discussed is a space-through charge transfer compound for OLEDs exhibiting thermally activated delayed fluoroscence. The compound includes a naphthalene core; an electron donor moiety D selected from carbazole and phenylcarbazole; and an electron acceptor moiety A selected from pyridine, diazine, triazole and Ph benzodiazole, wherein the electron donor moiety and the electron acceptor moiety are combined to first and eighth positions of the naphthalene core with a benzene linker, resp., according to the following formula:. The experimental process involved the reaction of 5-(4-Bromophenyl)pyrimidine(cas: 160377-42-4).Application of 160377-42-4

The Article related to charge transfer compound light emitting diode, Electric Phenomena: Photoconductivity, Photoconductors, Photovoltaic Effect, Photoelectric Devices and other aspects.Application of 160377-42-4

Referemce:
Pyrimidine | C4H4N2 – PubChem,
Pyrimidine – Wikipedia

On February 11, 2020, Xing, Qifeng; Feng, Peichuan; Chen, Yue; Hu, Lingfeng; Chen, Yili published a patent.HPLC of Formula: 160377-42-4 The title of the patent was Organic compounds and its applications. And the patent contained the following:

An organic compound having simple and easy implementation, readily available raw materials, suitable for mass production scale-up and used as light emitting layer in an OLED device is provided. The class of organic compounds is represented by the following structural formula I as an example. The application of organic compound used in organic electroluminescent device. The experimental process involved the reaction of 5-(4-Bromophenyl)pyrimidine(cas: 160377-42-4).HPLC of Formula: 160377-42-4

The Article related to organic compound application electroluminescent device, Heterocyclic Compounds (More Than One Hetero Atom): Other 6-Membered Rings, Three Or More Hetero Atoms and other aspects.HPLC of Formula: 160377-42-4

Referemce:
Pyrimidine | C4H4N2 – PubChem,
Pyrimidine – Wikipedia

On February 5, 2019, Xing, Qifeng; Li, Zhiyang; Liu, Shuyao; Ren, Xueyan published a patent.Recommanded Product: 160377-42-4 The title of the patent was 2,6,9,10-Tetrasubstituted anthracene compound, and its application in organic light-emitting device. And the patent contained the following:

The inventive organic light-emitting device comprises a substrate, an anode layer, a 2,6,9,10-tetrasubstituted anthracene compound-containing organic functional layer (I; where Ar1 is a substituted or unsubstituted nitrogen containing heteroaryl group; Ar3 is a substituted or unsubstituted Ph, naphthyl, or biphenyl group; Ar2 is a substituted or unsubstituted aryl or ring group; and R1 can be a hydrogen, alkyl, halogen, nitro, cyano, or aryl group) and a cathode layer. The organic functional layer comprises a hole injection layer, a hole transport layer, a light emitting layer, an electron transport layer, and an electron injection layer. One 2,6,9,10-tetrasubstituted anthracene compound (A1: 2,2′-((2,6-diphenylanthracene-9,10-diyl)bis(4,1-phenylene))dipyridine) is prepared by (1) stirring 2,6-dibromoanthracene-9,10-dione, phenylboronic acid, potassium carbonate, Pd2(dba)3, toluene, ethanol, and water under protection of nitrogen gas, heating to 100°C, and reacting under reflux for 12 h to obtain intermediate M2; (2) adding 2-(4-bromophenyl)pyridine and THF in a reactor, stirring, cooling to (-90)-(-80)°C, dropwise adding Bu lithium in 30 min, adding the intermediate M2, and stirring at room temperature for 8 h to obtain intermediate M3; (3) adding acetic acid in a reactor, stirring, heating to 60°C, adding the intermediate M3, KI, and sodium dihydrogen phosphate, and reacting under reflux at 120°C for 5 h. The invention has good voltage, efficiency and long service life. The experimental process involved the reaction of 5-(4-Bromophenyl)pyrimidine(cas: 160377-42-4).Recommanded Product: 160377-42-4

The Article related to organic light emitting device tetrasubstituted anthracene, Optical, Electron, and Mass Spectroscopy and Other Related Properties: Spectrometers and Optical Apparatus and other aspects.Recommanded Product: 160377-42-4

Referemce:
Pyrimidine | C4H4N2 – PubChem,
Pyrimidine – Wikipedia

Adib, Mehdi; Karimi-Nami, Rahman; Veisi, Hojat published an article in 2016, the title of the article was Palladium NPs supported on novel imino-pyridine-functionalized MWCNTs: efficient and highly reusable catalysts for the Suzuki-Miyaura and Sonogashira coupling reactions.Quality Control of 5-(4-Bromophenyl)pyrimidine And the article contains the following content:

In this article a new heterogeneous nanocatalyst based on palladium supported on functionalized multi-walled carbon nanotubes (MWCNTs) has been introduced. The synthetic process of the mentioned nanocatalyst, MWCNT-imino-pyridine/Pd, has been described. The characterization of the MWCNT-imino-pyridine/Pd was afforded by SEM, EDX, TEM, FTIR, ICP, and XRD. The surface structure of the materials was confirmed using Fourier transform IR (FTIR) spectroscopy. The catalytic activity of MWCNT-imino-pyridine/Pd was tested in Sonogashira and Suzuki-Miyaura cross-coupling reactions affording various derivatives of both aryl alkynes and biaryls. The catalyst can be readily recovered and recycled at least six times without significant loss of catalytic activity. The experimental process involved the reaction of 5-(4-Bromophenyl)pyrimidine(cas: 160377-42-4).Quality Control of 5-(4-Bromophenyl)pyrimidine

The Article related to palladium nanoparticle supported iminopyridine functionalized mwcnt, efficient highly reusable catalyst suzuki sonogashira coupling reaction, sonogashira suzuki crosscoupling reaction production derivative aryl alkyne biaryl and other aspects.Quality Control of 5-(4-Bromophenyl)pyrimidine

Referemce:
Pyrimidine | C4H4N2 – PubChem,
Pyrimidine – Wikipedia

Kazemnejadi, Milad; Sardarian, Ali Reza; Esmaeilpour, Mohsen published an article in 2019, the title of the article was Introduction of two polyvinyl alcohol resins for efficient solid support Cu-catalyzed N-arylation of α-aminoacids with aryl halides in aqueous media.Category: pyrimidines And the article contains the following content:

In this article, two polyvinyl alc. (PVA)-based resins were prepared by crosslinking of epoxidized PVA-chains using of 4-(4-aminobenzyl)benzenamine as a crosslinker and polymerization of acrylated PVA chains in the another approach. The prepared PVA resins showed well hydrophilic and swelling properties in various organic solvents, which are used in solid-phase organic synthesis (SPOS). Swelling properties of these resins were examined in DMF, THF, water, ethanol, methanol, dichloromethane, and dioxane. Furthermore, the both resins were characterized by FTIR and 1H-NMR and their properties such as epoxy equivalent weight (EEW) of epoxidized PVA and d. of the resins were determined by anal. methods. Then, α-amino acids such as L-aspartic acid, L-leucine, L-alanine, L-serine, L-valine, L-threonine, and L-tyrosine were immobilized on both resins through esterification reaction between these α-amino acids with the present hydroxyl groups on PVA resins, to carry out their solid-phase N-arylation reaction in the presence of CuI as a catalyst in milder and greener conditions than free resin protocols. Hydrolysis of the corresponding N-arylated α-amino acids immobilized on the resins gave the N-arylated α-amino acids in high to excellent yields. © 2019 Wiley Periodicals, Inc.J. Appl. Polym. Sci. 2019, 136, 47597. The experimental process involved the reaction of 5-(4-Bromophenyl)pyrimidine(cas: 160377-42-4).Category: pyrimidines

The Article related to amino acid arylation solid phase arylhalide green chem swelling, solid support recycling copper arylation polyvinyl alc resin hydrolysis, arylation reaction mechanism copper catalyst, aryl halide cross coupling reaction amino acid copper catalyst and other aspects.Category: pyrimidines

Referemce:
Pyrimidine | C4H4N2 – PubChem,
Pyrimidine – Wikipedia

On February 5, 1998, Murugesan, Natesan; Barrish, Joel C.; Stein, Philip D. published a patent.Computed Properties of 160377-42-4 The title of the patent was Preparation of heterocyclyl-substituted biphenylsulfonamide as endothelin antagonists. And the patent contained the following:

Compounds of formula (I; R1 and R2 are directly bonded to a ring carbon and are each independently hydrogen, alkyl or alkoxy, hydroxyl, halo, or amino; one of X and Y is N and the other is O: R3 and R4 are each directly bonded to a ring carbon and are each independently hydrogen, alkyl, alkenyl, alkynyl, alkoxy, cycloalkyl, cycloalkylalkyl, cycloalkenyl, cycloalkenylalkyl, aryl, aryloxy, aralkyl or aralkoxy, any of which may be substituted or R3 and R4 together may also be alkylene or alkenylene, either of which may be substituted, completing a 4- to 8-membered saturated, unsaturated or aromatic ring together with the carbon atoms to which they are attached; R11 – R14 are each independently are hydrogen alkyl, alkenyl, alkynyl, alkoxy, cycloalkyl, cycloalkylalkyl, cycloalkenyl, cycloalkenylalkyl, aryl, aryloxy, aralkyl, aralkoxy, or heterocyclyl, any of which may be substituted, halo, OH, cyano, NO2, CHO, CO2H, etc.; J, K, L, T, and U are each independently N or C, provided that at least one is N, and at most two are N; and when only one of J, K, L, T, and U is N, the N may be substituted with O- so that N-oxide is formed), which inhibit the activity of endothelin (no data), are prepared Also claimed is a method for treating endothelin-related disorders in a mammal, such as (1) hypertension, (2) pulmonary hypertension, (3) renal, glomerular, or mesangial cell disorders, (4) endotoxemia, (5) ischemia, (6) atherosclerosis, (7) restenosis, (8) subarachnoid hemorrhage, (9) prostatic hypertrophy, and (10) congestive heart failure, and a method for inhibiting cell growth. Said compound I is used in combination with at least one angiotensin II receptor antagonist, renin inhibitor, angiotensin converting enzyme (ACE) inhibitor, or a dual neutral endopeptidase-ACE inhibitor for treating the endothelin-related disorder. A pharmaceutical composition for the treating the endothelin-related disorders comprises said compound optionally in combination with at least one angiotensin II receptor antagonist, renin inhibitor, angiotensin converting enzyme (ACE) inhibitor, or a dual neutral endopeptidase-ACE inhibitor. Thus, 2-(4-bromophenyl)pyrimidine is coupled with 2-borono-N-(3,4-dimethyl-5-isoxazolyl)-N-[(2-methoxyethoxy)methyl]benzenesulfonamide in the presence of (Ph3P)4Pd in a mixture of toluene, 2 M aqueous Na2CO3, and 95% ethanol under reflux for 1.5 h to give the title compound, N-isoxazolylpyrimidinylbiphenylsulfonamide (II). The experimental process involved the reaction of 5-(4-Bromophenyl)pyrimidine(cas: 160377-42-4).Computed Properties of 160377-42-4

The Article related to angiotensin ii receptor antagonists, antiatherosclerotics, antihypertensives, benign prostatic hyperplasia, cell (renal, glomerular, or mesangial cell disorders), endotoxemia, growth inhibitors, animal role: spn (synthetic preparation), thu (therapeutic use), prep (preparation), biol (biological study), uses (uses), heart failure, ischemia, mesangium (disorders), subarachnoid hemorrhage and other aspects.Computed Properties of 160377-42-4

Referemce:
Pyrimidine | C4H4N2 – PubChem,
Pyrimidine – Wikipedia